Primary Biliary Cirrhosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis Interventions: Drug: TQA3526; Drug: Placebo to match TQA3526 Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2020 Category: Research Source Type: clinical trials
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition: Primary Biliary Cirrhosis Intervention: Sponsors: Benedetta Terziroli, MD; Fondazione Epatocentro Ticino; Vifor Pharma; Intercept Pharmaceuticals Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials